DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Biederman J, Krishnan S, Zhang Y et al.
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.
Clin Ther 2007;
29: 450-463
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.